Study of blood/tissue targets in suspected childhood brain tumors
Part of Cancer clinical trials.
This study looks at biological “targets” (things in the body) to help guide future medical treatments for children and teens with suspected craniopharyngioma. It will collect and analyze tissue samples from planned care to understand what therapies might work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 0 to 21 years.
- You have a diagnosis or strong suspicion of craniopharyngioma (a childhood brain tumor near the pituitary).
- Your planned care includes getting a tissue sample (biopsy or surgery tissue).
- The tissue test (final pathology) must confirm adamantinomatous craniopharyngioma.
- A tissue specimen must be available for the study to use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a targeted medicine approach for high-grade glioma (a fast-growing brain tumor) and some diffuse midline tumors, including DIPG. It may help by matching treatment to tumor biology using tumor testing done before or around starting standard therapy.
This study looks at brain tumor samples from children and young adults after surgery to learn more about the tumors and find better treatments. It may help researchers develop new therapies for these tumors.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
This study collects biological samples from adults with a confirmed brain tumor. Samples may help researchers better understand brain tumors and improve future treatments.
This study looks at how young people with certain brain tumors respond to treatment. It aims to understand why some tumors resist therapy, which may help improve future treatments.
This trial studies newly diagnosed or progressing brain tumors (grade 2–4 gliomas) to better understand the disease using tumor tissue and blood samples. It may help doctors learn which treatments could work best for different tumor types by matching tumor material to blood results.
Hear when a new Craniopharyngioma, Child trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.